Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
- 31 March 2007
- journal article
- research article
- Published by Elsevier BV in Chest
- Vol. 131 (3), 897-899
- https://doi.org/10.1378/chest.06-2101
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The distance-saturation product predicts mortality in idiopathic pulmonary fibrosisRespiratory Medicine, 2006
- Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary FibrosisChest, 2006
- A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung diseaseVascular Pharmacology, 2006
- The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2005
- Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Prognostic Significance of the Histologic Pattern of Interstitial Pneumonia in Patients Presenting with the Clinical Entity of Cryptogenic Fibrosing AlveolitisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Pulmonary Hemodynamics in Idiopathic Pulmonary Fibrosis and Other Interstitial Pulmonary DiseasesRespiration, 1983